Literature DB >> 1926130

DNA typing for HLA-DR, and -DP alleles in a Chinese population using the polymerase chain reaction (PCR) and oligonucleotide probes.

X J Gao1, Y P Sun, J B An, M Fernandez-Viña, J N Qou, L Lin, P Stastny.   

Abstract

We have determined alleles of HLA-DRB1, DRB3, DRB5, DQA1, DQB1, and DPB1 loci in 91 unrelated healthy individuals from North China. Group-specific PCR primers were employed for the analysis of subsets of DR1, DR2, DR4, DRw52, and DPB. With allele-specific probes, 22 DRB1, 8 DQA1, 13 DQB1, and 12 DPB1 alleles were found in this panel. Allele frequencies showed that 25.3% of the subjects had DR7 and 26.4% had DR9, only 5.5% had DRB1*0301 (DRw17). In the DR4 group, DRB1*0405 (Dw15, 8.8%) and 0406 (KT2, 9.9%) were the most prevalent alleles. DRB1*0404 (Dw14.1), 0407 (Dw13.2) and 0408 (Dw14.2) were absent and the other alleles of the DR4 group were rare. The most common DRw6 subset was DRB1*1401 (8.8%). DRB1*0802 and 0803 were present (2.2%, 6.6%), and DRB1*0801 was not found. Associations with DQA1 and DQB1 were generally similar to those found in other populations. DPB1*0501 was the most frequent (60.2%) allele at the DPB1 locus. Overall our study shows that the distribution of class II alleles in a population from Mainland China is quite different from other ethnic groups. The high frequency of the KT2 subset of DR4. (DRB1*0406) and of DPB1*0501 are the most striking features found. A new type of DR4 was determined in one subject. It was like DR4-Dw15 (DRB1*0405) but, according to our hybridization patterns, it encoded valine instead of glycine in position 86. It is now called DRB1*0410.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1926130     DOI: 10.1111/j.1399-0039.1991.tb02031.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Languages, geography and HLA haplotypes in native American and Asian populations.

Authors:  M V Monsalve; A Helgason; D V Devine
Journal:  Proc Biol Sci       Date:  1999-11-07       Impact factor: 5.349

2.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

3.  HLA-DR polymorphism in a Senegalese Mandenka population: DNA oligotyping and population genetics of DRB1 specificities.

Authors:  J M Tiercy; A Sanchez-Mazas; L Excoffier; X Shi-Isaac; M Jeannet; B Mach; A Langaney
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

4.  Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201.

Authors:  I Ikaheimo; S Silvennoinen-Kassinen; J Karvonen; T Jarvinen; A Tiilikainen
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

5.  AB1: a novel HLA-DPB1 allele found in one third of an Australian population.

Authors:  X Gao; A Veale; S Serjeantson
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Nucleotide sequence of a novel HLA-DPB1 allele.

Authors:  J W Dekker; L Croft; S Easteal
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

7.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.

Authors:  Owen D Solberg; Steven J Mack; Alex K Lancaster; Richard M Single; Yingssu Tsai; Alicia Sanchez-Mazas; Glenys Thomson
Journal:  Hum Immunol       Date:  2008-06-09       Impact factor: 2.850

8.  Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups.

Authors:  M A Fernandez-Viña; X J Gao; M E Moraes; J R Moraes; I Salatiel; S Miller; J Tsai; Y P Sun; J B An; Z Layrisse
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

9.  HLA-DPB1 alleles in a population from south China.

Authors:  M Falco; Y Sun; M A Fernandez-Viña; P Stastny
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.